-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RtcV8vKsD5EyS4v6chitX63Iz5eRxtorDdES53HevEpZ3dxj0YxhwW65rJkBs6SY 6tAuQVMpQFtUVN53uyHmgg== 0000950124-07-003771.txt : 20070725 0000950124-07-003771.hdr.sgml : 20070725 20070725164434 ACCESSION NUMBER: 0000950124-07-003771 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070720 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20070725 DATE AS OF CHANGE: 20070725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 07999737 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 8-K 1 v32140e8vk.htm FORM 8-K e8vk
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Earliest Event Reported): July 20, 2007
CYTRX CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
     
000-15327
(Commission File Number) 		  58-1642740
(I.R.S. Employer Identification No.)
     
11726 San Vicente Boulevard, Suite 650
Los Angeles, California
(Address of Principal Executive Offices) 		 
90049
(Zip Code)
(310) 826-5648
(Registrant’s Telephone Number, Including Area Code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

ITEM 1.01 Entry into a Material Definitive Agreement
     On July 20, 2007, CytRx Corporation (“we,” “us,” “CytRx” or the “Company”) entered into a lease with BMR-3030 Bunker Hill Street LLC, as landlord, as part of our previously announced relocation of our laboratory facility of San Diego, California, and other operational changes.
     Under the lease, we will occupy approximately 10,000 square feet of office and laboratory space at 3030 Bunker Hill Street, San Diego, California. The lease is for a term of three years expiring on July 31, 2010, unless earlier terminated in accordance with the lease.
     The lease is a so-called triple net lease, under which our monthly payments will include rent of approximately $18,000, plus our pro rata share of the landlord’s “operating expenses” (as defined) of the premises. Our allocable current monthly operating expenses are estimated to be approximately $16,300. Rent under the lease is subject to an annual increase of 3% on each anniversary of the commencement of the lease term, which is expected to be August 1, 2007.

2

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  CYTRX CORPORATION
 		  
  By:   /s/ Matthew Natalizio    
    Matthew Natalizio   
    Chief Financial Officer   
Dated: July 24, 2007

3

-----END PRIVACY-ENHANCED MESSAGE-----